VRNA

Verona Pharma
VRNA

Overview Fund Activity

14 hedge funds and large institutions have $33.7M invested in Verona Pharma in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.28%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
2
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WS
1
Wedbush Securities
California
$466K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$88K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$72K
4
UBS Group
4
UBS Group
Switzerland
$58K
5
Deutsche Bank
5
Deutsche Bank
Germany
$2K

Top Sellers

1
PC
1
Polar Capital
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
O
1
OrbiMed
New York
$7.19M 1,250,396 – –
NMC
2
NEA Management Company
Maryland
$7.01M 1,219,674 – –
A
3
Abingworth
United Kingdom
$5.23M 901,943 – –
VP
4
venBio Partners
California
$5.03M 875,000 – –
NHAS
5
Novo Holdings A/S
Denmark
$4.26M 740,740 – –
ACM
6
Aisling Capital Management
New York
$2.55M 443,596 – –
TCM
7
Tekla Capital Management
Massachusetts
$1.58M 275,000 – –
WS
8
Wedbush Securities
California
$466K 81,100 +50,785 +168%
IWM
9
IHT Wealth Management
Illinois
$118K 20,460 – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$88K 15,375 +15,375 New
Renaissance Technologies
11
Renaissance Technologies
New York
$72K 12,500 +12,500 New
UBS Group
12
UBS Group
Switzerland
$58K 10,055 +8,940 +802%
US Bancorp
13
US Bancorp
Minnesota
$22K 3,840 – –
Deutsche Bank
14
Deutsche Bank
Germany
$2K 442 +68 +18%
PC
15
Polar Capital
United Kingdom
– – -100,000 Closed
CFGS
16
Concourse Financial Group Securities
Alabama
– – – –